-
1
-
-
3042844293
-
Cancer immunotherapy: A treatment for the masses
-
J. N. Blattman, P. D. Greenberg, Cancer immunotherapy: A treatment for the masses. Science 305, 200-205 (2004).
-
(2004)
Science
, vol.305
, pp. 200-205
-
-
Blattman, J.N.1
Greenberg, P.D.2
-
2
-
-
84858758766
-
Adoptive immunotherapy for cancer: Harnessing the T cell response
-
N. P. Restifo, M. E. Dudley, S. A. Rosenberg, Adoptive immunotherapy for cancer: Harnessing the T cell response. Nat. Rev. Immunol. 12, 269-281 (2012).
-
(2012)
Nat. Rev. Immunol.
, vol.12
, pp. 269-281
-
-
Restifo, N.P.1
Dudley, M.E.2
Rosenberg, S.A.3
-
3
-
-
65249101637
-
The promise and potential pitfalls of chimeric antigen receptors
-
M. Sadelain, R. Brentjens, I. Rivière, The promise and potential pitfalls of chimeric antigen receptors. Curr. Opin. Immunol. 21, 215-223 (2009).
-
(2009)
Curr. Opin. Immunol.
, vol.21
, pp. 215-223
-
-
Sadelain, M.1
Brentjens, R.2
Rivière, I.3
-
4
-
-
84867742083
-
Engineered T cells for anti-cancer therapy
-
C. J. Turtle, M. Hudecek, M. C. Jensen, S. R. Riddell, Engineered T cells for anti-cancer therapy. Curr. Opin. Immunol. 24, 633-639 (2012).
-
(2012)
Curr. Opin. Immunol.
, vol.24
, pp. 633-639
-
-
Turtle, C.J.1
Hudecek, M.2
Jensen, M.C.3
Riddell, S.R.4
-
5
-
-
84861576998
-
Advances in graft-versus-host disease biology and therapy
-
B. R. Blazar, W. J. Murphy, M. Abedi, Advances in graft-versus-host disease biology and therapy. Nat. Rev. Immunol. 12, 443-458 (2012).
-
(2012)
Nat. Rev. Immunol.
, vol.12
, pp. 443-458
-
-
Blazar, B.R.1
Murphy, W.J.2
Abedi, M.3
-
6
-
-
47249124078
-
Human regulatory T cells: Role in autoimmune disease and therapeutic opportunities
-
T. M. Brusko, A. L. Putnam, J. A. Bluestone, Human regulatory T cells: Role in autoimmune disease and therapeutic opportunities. Immunol. Rev. 223, 371-390 (2008).
-
(2008)
Immunol. Rev.
, vol.223
, pp. 371-390
-
-
Brusko, T.M.1
Putnam, A.L.2
Bluestone, J.A.3
-
7
-
-
80051775476
-
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia
-
M. Kalos, B. L. Levine, D. L. Porter, S. Katz, S. A. Grupp, A. Bagg, C. H. June, T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73 (2011).
-
(2011)
Sci. Transl. Med.
, vol.3
-
-
Kalos, M.1
Levine, B.L.2
Porter, D.L.3
Katz, S.4
Grupp, S.A.5
Bagg, A.6
June, C.H.7
-
8
-
-
80455179612
-
Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
-
R. J. Brentjens, I. Rivière, J. H. Park, M. L. Davila, X. Wang, J. Stefanski, C. Taylor, R. Yeh, S. Bartido, O. Borquez-Ojeda, M. Olszewska, Y. Bernal, H. Pegram, M. Przybylowski, D. Hollyman, Y. Usachenko, D. Pirraglia, J. Hosey, E. Santos, E. Halton, P. Maslak, D. Scheinberg, J. Jurcic, M. Heaney, G. Heller, M. Frattini, M. Sadelain, Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 118, 4817-4828 (2011).
-
(2011)
Blood
, vol.118
, pp. 4817-4828
-
-
Brentjens, R.J.1
Rivière, I.2
Park, J.H.3
Davila, M.L.4
Wang, X.5
Stefanski, J.6
Taylor, C.7
Yeh, R.8
Bartido, S.9
Borquez-Ojeda, O.10
Olszewska, M.11
Bernal, Y.12
Pegram, H.13
Przybylowski, M.14
Hollyman, D.15
Usachenko, Y.16
Pirraglia, D.17
Hosey, J.18
Santos, E.19
Halton, E.20
Maslak, P.21
Scheinberg, D.22
Jurcic, J.23
Heaney, M.24
Heller, G.25
Frattini, M.26
Sadelain, M.27
more..
-
9
-
-
84876005284
-
CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia
-
R. J. Brentjens, M. L. Davila, I. Riviere, J. Park, X. Wang, L. G. Cowell, S. Bartido, J. Stefanski, C. Taylor, M. Olszewska, O. Borquez-Ojeda, J. Qu, T. Wasielewska, Q. He, Y. Bernal, I. V. Rijo, C. Hedvat, R. Kobos, K. Curran, P. Steinherz, J. Jurcic, T. Rosenblat, P. Maslak, M. Frattini, M. Sadelain, CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci. Transl. Med. 5, 177ra38 (2013).
-
(2013)
Sci. Transl. Med.
, vol.5
-
-
Brentjens, R.J.1
Davila, M.L.2
Riviere, I.3
Park, J.4
Wang, X.5
Cowell, L.G.6
Bartido, S.7
Stefanski, J.8
Taylor, C.9
Olszewska, M.10
Borquez-Ojeda, O.11
Qu, J.12
Wasielewska, T.13
He, Q.14
Bernal, Y.15
Rijo, I.V.16
Hedvat, C.17
Kobos, R.18
Curran, K.19
Steinherz, P.20
Jurcic, J.21
Rosenblat, T.22
Maslak, P.23
Frattini, M.24
Sadelain, M.25
more..
-
10
-
-
77950475517
-
Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2
-
R. A. Morgan, J. C. Yang, M. Kitano, M. E. Dudley, C. M. Laurencot, S. A. Rosenberg, Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2. Mol. Ther. 18, 843-851 (2010).
-
(2010)
Mol. Ther.
, vol.18
, pp. 843-851
-
-
Morgan, R.A.1
Yang, J.C.2
Kitano, M.3
Dudley, M.E.4
Laurencot, C.M.5
Rosenberg, S.A.6
-
11
-
-
84873991752
-
Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy
-
R. A. Morgan, N. Chinnasamy, D. Abate-Daga, A. Gros, P. F. Robbins, Z. Zheng, M. E. Dudley, S. A. Feldman, J. C. Yang, R. M. Sherry, G. Q. Phan, M. S. Hughes, U. S. Kammula, A. D. Miller, C. J. Hessman, A. A. Stewart, N. P. Restifo, M. M. Quezado, M. Alimchandani, A. Z. Rosenberg, A. Nath, T. Wang, B. Bielekova, S. C. Wuest, N. Akula, F. J. McMahon, S. Wilde, B. Mosetter, D. J. Schendel, C. M. Laurencot, S. A. Rosenberg, Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J. Immunother. 36, 133-151 (2013).
-
(2013)
J. Immunother.
, vol.36
, pp. 133-151
-
-
Morgan, R.A.1
Chinnasamy, N.2
Abate-Daga, D.3
Gros, A.4
Robbins, P.F.5
Zheng, Z.6
Dudley, M.E.7
Feldman, S.A.8
Yang, J.C.9
Sherry, R.M.10
Phan, G.Q.11
Hughes, M.S.12
Kammula, U.S.13
Miller, A.D.14
Hessman, C.J.15
Stewart, A.A.16
Restifo, N.P.17
Quezado, M.M.18
Alimchandani, M.19
Rosenberg, A.Z.20
Nath, A.21
Wang, T.22
Bielekova, B.23
Wuest, S.C.24
Akula, N.25
McMahon, F.J.26
Wilde, S.27
Mosetter, B.28
Schendel, D.J.29
Laurencot, C.M.30
Rosenberg, S.A.31
more..
-
12
-
-
84883866836
-
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells
-
B. J. Cameron, A. B. Gerry, J. Dukes, J. V. Harper, V. Kannan, F. C. Bianchi, F. Grand, J. E. Brewer, M. Gupta, G. Plesa, G. Bossi, A. Vuidepot, A. S. Powlesland, A. Legg, K. J. Adams, A. D. Bennett, N. J. Pumphrey, D. D. Williams, G. Binder-Scholl, I. Kulikovskaya, B. L. Levine, J. L. Riley, A. Varela-Rohena, E. A. Stadtmauer, A. P. Rapoport, G. P. Linette, C. H. June, N. J. Hassan, M. Kalos, B. K. Jakobsen, Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells. Sci. Transl. Med. 5, 197ra103 (2013).
-
(2013)
Sci. Transl. Med.
, vol.5
-
-
Cameron, B.J.1
Gerry, A.B.2
Dukes, J.3
Harper, J.V.4
Kannan, V.5
Bianchi, F.C.6
Grand, F.7
Brewer, J.E.8
Gupta, M.9
Plesa, G.10
Bossi, G.11
Vuidepot, A.12
Powlesland, A.S.13
Legg, A.14
Adams, K.J.15
Bennett, A.D.16
Pumphrey, N.J.17
Williams, D.D.18
Binder-Scholl, G.19
Kulikovskaya, I.20
Levine, B.L.21
Riley, J.L.22
Varela-Rohena, A.23
Stadtmauer, E.A.24
Rapoport, A.P.25
Linette, G.P.26
June, C.H.27
Hassan, N.J.28
Kalos, M.29
Jakobsen, B.K.30
more..
-
13
-
-
84880730689
-
Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma
-
G. P. Linette, E. A. Stadtmauer, M. V. Maus, A. P. Rapoport, B. L. Levine, L. Emery, L. Litzky, A. Bagg, B. M. Carreno, P. J. Cimino, G. K. Binder-Scholl, D. P. Smethurst, A. B. Gerry, N. J. Pumphrey, A. D. Bennett, J. E. Brewer, J. Dukes, J. Harper, H. K. Tayton-Martin, B. K. Jakobsen, N. J. Hassan, M. Kalos, C. H. June, Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma. Blood 122, 863-871 (2013).
-
(2013)
Blood
, vol.122
, pp. 863-871
-
-
Linette, G.P.1
Stadtmauer, E.A.2
Maus, M.V.3
Rapoport, A.P.4
Levine, B.L.5
Emery, L.6
Litzky, L.7
Bagg, A.8
Carreno, B.M.9
Cimino, P.J.10
Binder-Scholl, G.K.11
Smethurst, D.P.12
Gerry, A.B.13
Pumphrey, N.J.14
Bennett, A.D.15
Brewer, J.E.16
Dukes, J.17
Harper, J.18
Tayton-Martin, H.K.19
Jakobsen, B.K.20
Hassan, N.J.21
Kalos, M.22
June, C.H.23
more..
-
14
-
-
65349171937
-
Graft-versus-host disease
-
J. L. Ferrara, J. E. Levine, P. Reddy, E. Holler, Graft-versus-host disease. Lancet 373, 1550-1561 (2009).
-
(2009)
Lancet
, vol.373
, pp. 1550-1561
-
-
Ferrara, J.L.1
Levine, J.E.2
Reddy, P.3
Holler, E.4
-
15
-
-
84872258471
-
New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation
-
E. Kotsiou, J. K. Davies, New ways to separate graft-versus-host disease and graft-versus-tumour effects after allogeneic haematopoietic stem cell transplantation. Br. J. Haematol. 160, 133-145 (2013).
-
(2013)
Br. J. Haematol.
, vol.160
, pp. 133-145
-
-
Kotsiou, E.1
Davies, J.K.2
-
16
-
-
0034781710
-
A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease
-
G. Akpek, S. M. Lee, V. Anders, G. B. Vogelsang, A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease. Biol. Blood Marrow Transplant. 7, 495-502 (2001).
-
(2001)
Biol. Blood Marrow Transplant.
, vol.7
, pp. 495-502
-
-
Akpek, G.1
Lee, S.M.2
Anders, V.3
Vogelsang, G.B.4
-
17
-
-
77949768669
-
Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation
-
M. T. Lupo-Stanghellini, E. Provasi, A. Bondanza, F. Ciceri, C. Bordignon, C. Bonini, Clinical impact of suicide gene therapy in allogeneic hematopoietic stem cell transplantation. Hum. Gene Ther. 21, 241-250 (2010).
-
(2010)
Hum. Gene Ther.
, vol.21
, pp. 241-250
-
-
Lupo-Stanghellini, M.T.1
Provasi, E.2
Bondanza, A.3
Ciceri, F.4
Bordignon, C.5
Bonini, C.6
-
18
-
-
80455162464
-
Inducible apoptosis as a safety switch for adoptive cell therapy
-
A. Di Stasi, S. K. Tey, G. Dotti, Y. Fujita, A. Kennedy-Nasser, C. Martinez, K. Straathof, E. Liu, A. G. Durett, B. Grilley, H. Liu, C. R. Cruz, B. Savoldo, A. P. Gee, J. Schindler, R. A. Krance, H. E. Heslop, D. M. Spencer, C. M. Rooney, M. K. Brenner, Inducible apoptosis as a safety switch for adoptive cell therapy. N. Engl. J. Med. 365, 1673-1683 (2011).
-
(2011)
N. Engl. J. Med.
, vol.365
, pp. 1673-1683
-
-
Di Stasi, A.1
Tey, S.K.2
Dotti, G.3
Fujita, Y.4
Kennedy-Nasser, A.5
Martinez, C.6
Straathof, K.7
Liu, E.8
Durett, A.G.9
Grilley, B.10
Liu, H.11
Cruz, C.R.12
Savoldo, B.13
Gee, A.P.14
Schindler, J.15
Krance, R.A.16
Heslop, H.E.17
Spencer, D.M.18
Rooney, C.M.19
Brenner, M.K.20
more..
-
19
-
-
77954242723
-
An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy
-
I. Vogler, S. Newrzela, S. Hartmann, N. Schneider, D. von Laer, U. Koehl,M. Grez, An improved bicistronic CD20/tCD34 vector for efficient purification and in vivo depletion of gene-modified T cells for adoptive immunotherapy. Mol. Ther. 18, 1330-1338 (2010).
-
(2010)
Mol. Ther.
, vol.18
, pp. 1330-1338
-
-
Vogler, I.1
Newrzela, S.2
Hartmann, S.3
Schneider, N.4
Von Laer, D.5
Koehl, U.6
Grez, M.7
-
20
-
-
38649127824
-
A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer
-
E. Kieback, J. Charo, D. Sommermeyer, T. Blankenstein, W. Uckert, A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer. Proc. Natl. Acad. Sci. U.S.A. 105, 623-628 (2008).
-
(2008)
Proc. Natl. Acad. Sci. U.S.A.
, vol.105
, pp. 623-628
-
-
Kieback, E.1
Charo, J.2
Sommermeyer, D.3
Blankenstein, T.4
Uckert, W.5
-
21
-
-
84858766182
-
The blockade of immune checkpoints in cancer immunotherapy
-
D. M. Pardoll, The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012).
-
(2012)
Nat. Rev. Cancer
, vol.12
, pp. 252-264
-
-
Pardoll, D.M.1
-
22
-
-
80054875641
-
Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps
-
P. Sharma, K. Wagner, J. D. Wolchok, J. P. Allison, Novel cancer immunotherapy agents with survival benefit: Recent successes and next steps. Nat. Rev. Cancer 11, 805-812 (2011).
-
(2011)
Nat. Rev. Cancer
, vol.11
, pp. 805-812
-
-
Sharma, P.1
Wagner, K.2
Wolchok, J.D.3
Allison, J.P.4
-
23
-
-
0028867420
-
Loss of CTLA-4 leads to massive lymphoproliferation and fatalmultiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
-
E. A. Tivol, F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, A. H. Sharpe, Loss of CTLA-4 leads to massive lymphoproliferation and fatalmultiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547 (1995).
-
(1995)
Immunity
, vol.3
, pp. 541-547
-
-
Tivol, E.A.1
Borriello, F.2
Schweitzer, A.N.3
Lynch, W.P.4
Bluestone, J.A.5
Sharpe, A.H.6
-
24
-
-
0033180181
-
Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor
-
H. Nishimura, M. Nose, H. Hiai, N. Minato, T. Honjo, Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11, 141-151 (1999).
-
(1999)
Immunity
, vol.11
, pp. 141-151
-
-
Nishimura, H.1
Nose, M.2
Hiai, H.3
Minato, N.4
Honjo, T.5
-
26
-
-
27144496045
-
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms
-
R. V. Parry, J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein, S. V. Kobayashi, P. S. Linsley, C. B. Thompson, J. L. Riley, CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25, 9543-9553 (2005).
-
(2005)
Mol. Cell. Biol.
, vol.25
, pp. 9543-9553
-
-
Parry, R.V.1
Chemnitz, J.M.2
Frauwirth, K.A.3
Lanfranco, A.R.4
Braunstein, I.5
Kobayashi, S.V.6
Linsley, P.S.7
Thompson, C.B.8
Riley, J.L.9
-
27
-
-
84862859820
-
Safety, activity, and immune correlates of anti-PD-1 antibody in cancer
-
S. L. Topalian, F. S.Hodi, J. R. Brahmer, S. N. Gettinger, D. C. Smith,D. F. McDermott, J. D. Powderly, R. D. Carvajal, J. A. Sosman, M. B. Atkins, P. D. Leming, D. R. Spigel, S. J. Antonia, L. Horn, C. G. Drake, D. M. Pardoll, L. Chen, W. H. Sharfman, R. A. Anders, J. M. Taube, T. L. McMiller, H. Xu, A. J. Korman, M. Jure-Kunkel, S. Agrawal, D. McDonald,G. D. Kollia, A. Gupta, J. M. Wigginton, M. Sznol, Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366, 2443-2454 (2012).
-
(2012)
N. Engl. J. Med.
, vol.366
, pp. 2443-2454
-
-
Topalian, S.L.1
Hodi, F.S.2
Brahmer, J.R.3
Gettinger, S.N.4
Smith, D.C.5
McDermott, D.F.6
Powderly, J.D.7
Carvajal, R.D.8
Sosman, J.A.9
Atkins, M.B.10
Leming, P.D.11
Spigel, D.R.12
Antonia, S.J.13
Horn, L.14
Drake, C.G.15
Pardoll, D.M.16
Chen, L.17
Sharfman, W.H.18
Anders, R.A.19
Taube, J.M.20
McMiller, T.L.21
Xu, H.22
Korman, A.J.23
Jure-Kunkel, M.24
Agrawal, S.25
McDonald, D.26
Kollia, G.D.27
Gupta, A.28
Wigginton, J.M.29
Sznol, M.30
more..
-
28
-
-
77954801079
-
Improved survival with ipilimumab in patients with metastatic melanoma
-
F. S. Hodi, S. J. O'Day, D. F. McDermott, R. W. Weber, J. A. Sosman, J. B. Haanen, R. Gonzalez, C. Robert, D. Schadendorf, J. C. Hassel, W. Akerley, A. J. van den Eertwegh, J. Lutzky, P. Lorigan, J. M. Vaubel, G. P. Linette, D. Hogg, C. H. Ottensmeier, C. Lebbé, C. Peschel, I. Quirt, J. I. Clark, J. D. Wolchok, J. S. Weber, J. Tian, M. J. Yellin, G. M. Nichol, A. Hoos, W. J. Urba, Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723 (2010).
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 711-723
-
-
Hodi, F.S.1
O'Day, S.J.2
McDermott, D.F.3
Weber, R.W.4
Sosman, J.A.5
Haanen, J.B.6
Gonzalez, R.7
Robert, C.8
Schadendorf, D.9
Hassel, J.C.10
Akerley, W.11
Van Den Eertwegh, A.J.12
Lutzky, J.13
Lorigan, P.14
Vaubel, J.M.15
Linette, G.P.16
Hogg, D.17
Ottensmeier, C.H.18
Lebbé, C.19
Peschel, C.20
Quirt, I.21
Clark, J.I.22
Wolchok, J.D.23
Weber, J.S.24
Tian, J.25
Yellin, M.J.26
Nichol, G.M.27
Hoos, A.28
Urba, W.J.29
more..
-
29
-
-
78651072784
-
+ T-cell memory formation, function, and maintenance
-
+ T-cell memory formation, function, and maintenance. Proc. Natl. Acad. Sci. U.S.A. 108, 266-271 (2011).
-
(2011)
Proc. Natl. Acad. Sci. U.S.A.
, vol.108
, pp. 266-271
-
-
Pedicord, V.A.1
Montalvo, W.2
Leiner, I.M.3
Allison, J.P.4
-
30
-
-
62249172189
-
Enhancing SIV-specific immunity in vivo by PD-1 blockade
-
V. Velu, K. Titanji, B. Zhu, S. Husain, A. Pladevega, L. Lai, T. H. Vanderford, L. Chennareddi, G. Silvestri, G. J. Freeman, R. Ahmed, R. R. Amara, Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458, 206-210 (2009).
-
(2009)
Nature
, vol.458
, pp. 206-210
-
-
Velu, V.1
Titanji, K.2
Zhu, B.3
Husain, S.4
Pladevega, A.5
Lai, L.6
Vanderford, T.H.7
Chennareddi, L.8
Silvestri, G.9
Freeman, G.J.10
Ahmed, R.11
Amara, R.R.12
-
31
-
-
25444524262
-
Targeted elimination of prostate cancer by genetically directed human T lymphocytes
-
T. P. Gade, W. Hassen, E. Santos, G. Gunset, A. Saudemont, M. C. Gong, R. Brentjens, X. S. Zhong, M. Stephan, J. Stefanski, C. Lyddane, J. R. Osborne, I. M. Buchanan, S. J. Hall, W. D. Heston, I. Rivière, S. M. Larson, J. A. Koutcher, M. Sadelain, Targeted elimination of prostate cancer by genetically directed human T lymphocytes. Cancer Res. 65, 9080-9088 (2005).
-
(2005)
Cancer Res.
, vol.65
, pp. 9080-9088
-
-
Gade, T.P.1
Hassen, W.2
Santos, E.3
Gunset, G.4
Saudemont, A.5
Gong, M.C.6
Brentjens, R.7
Zhong, X.S.8
Stephan, M.9
Stefanski, J.10
Lyddane, C.11
Osborne, J.R.12
Buchanan, I.M.13
Hall, S.J.14
Heston, W.D.15
Rivière, I.16
Larson, S.M.17
Koutcher, J.A.18
Sadelain, M.19
-
32
-
-
84877669593
-
The basic principles of chimeric antigen receptor design
-
M. Sadelain, R. Brentjens, I. Rivière, The basic principles of chimeric antigen receptor design. Cancer Discov. 3, 388-398 (2013).
-
(2013)
Cancer Discov.
, vol.3
, pp. 388-398
-
-
Sadelain, M.1
Brentjens, R.2
Rivière, I.3
-
33
-
-
33645576804
-
Expression of prostate-specific membrane antigen in normal and malignant human tissues
-
Y. Kinoshita, K. Kuratsukuri, S. Landas, K. Imaida, P. M. Rovito Jr., C. Y. Wang, G. P. Haas, Expression of prostate-specific membrane antigen in normal and malignant human tissues. World J. Surg. 30, 628-636 (2006).
-
(2006)
World J. Surg.
, vol.30
, pp. 628-636
-
-
Kinoshita, Y.1
Kuratsukuri, K.2
Landas, S.3
Imaida, K.4
Rovito Jr., P.M.5
Wang, C.Y.6
Haas, G.P.7
-
34
-
-
0036137615
-
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRz/CD28 receptor
-
J. Maher, R. J. Brentjens, G. Gunset, I. Rivière, M. Sadelain, Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRz/CD28 receptor. Nat. Biotechnol. 20, 70-75 (2002).
-
(2002)
Nat. Biotechnol.
, vol.20
, pp. 70-75
-
-
Maher, J.1
Brentjens, R.J.2
Gunset, G.3
Rivière, I.4
Sadelain, M.5
-
36
-
-
77955651021
-
A simple and sensitive method for measuring tumor-specific T cell cytotoxicity
-
X. Fu, L. Tao, A. Rivera, S. Williamson, X. T. Song, N. Ahmed, X. Zhang, A simple and sensitive method for measuring tumor-specific T cell cytotoxicity. PLOS One 5, e11867 (2010).
-
(2010)
PLOS One
, vol.5
-
-
Fu, X.1
Tao, L.2
Rivera, A.3
Williamson, S.4
Song, X.T.5
Ahmed, N.6
Zhang, X.7
-
37
-
-
34848842554
-
Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts
-
R. J. Brentjens, E. Santos, Y. Nikhamin, R. Yeh, M. Matsushita, K. La Perle, A. Quintás-Cardama, S. M. Larson, M. Sadelain, Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin. Cancer Res. 13, 5426-5435 (2007).
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 5426-5435
-
-
Brentjens, R.J.1
Santos, E.2
Nikhamin, Y.3
Yeh, R.4
Matsushita, M.5
La Perle, K.6
Quintás-Cardama, A.7
Larson, S.M.8
Sadelain, M.9
-
38
-
-
77951746241
-
IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
-
J. C. Markley, M. Sadelain, IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice. Blood 115, 3508-3519 (2010).
-
(2010)
Blood
, vol.115
, pp. 3508-3519
-
-
Markley, J.C.1
Sadelain, M.2
-
39
-
-
3142688997
-
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
-
J. M. Chemnitz, R. V. Parry, K. E. Nichols, C. H. June, J. L. Riley, SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J. Immunol. 173, 945-954 (2004).
-
(2004)
J. Immunol.
, vol.173
, pp. 945-954
-
-
Chemnitz, J.M.1
Parry, R.V.2
Nichols, K.E.3
June, C.H.4
Riley, J.L.5
-
40
-
-
84864324543
-
Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2
-
T. Yokosuka, M. Takamatsu, W. Kobayashi-Imanishi, A. Hashimoto-Tane, M. Azuma, T. Saito, Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209, 1201-1217 (2012).
-
(2012)
J. Exp. Med.
, vol.209
, pp. 1201-1217
-
-
Yokosuka, T.1
Takamatsu, M.2
Kobayashi-Imanishi, W.3
Hashimoto-Tane, A.4
Azuma, M.5
Saito, T.6
-
41
-
-
45449115527
-
Line of attack: NK cell specificity and integration of signals
-
Y. T. Bryceson, E. O. Long, Line of attack: NK cell specificity and integration of signals. Curr. Opin. Immunol. 20, 344-352 (2008).
-
(2008)
Curr. Opin. Immunol.
, vol.20
, pp. 344-352
-
-
Bryceson, Y.T.1
Long, E.O.2
-
42
-
-
82655184651
-
The PDL1-PD1 axis converts human TH1 cells into regulatory T cells
-
Downloaded from stm.sciencemag.org on December 28, 2013
-
S. Amarnath, C. W. Mangus, J. C. Wang, F. Wei, A. He, V. Kapoor, J. E. Foley, P. R. Massey, T. C. Felizardo, J. L. Riley, B. L. Levine, C. H. June, J. A. Medin, D. H. Fowler, The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci. Transl. Med. 3, 111ra120 (2011). Downloaded from stm.sciencemag.org on December 28, 2013
-
(2011)
Sci. Transl. Med.
, vol.3
-
-
Amarnath, S.1
Mangus, C.W.2
Wang, J.C.3
Wei, F.4
He, A.5
Kapoor, V.6
Foley, J.E.7
Massey, P.R.8
Felizardo, T.C.9
Riley, J.L.10
Levine, B.L.11
June, C.H.12
Medin, J.A.13
Fowler, D.H.14
-
43
-
-
45149111788
-
Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy
-
K. S. Peggs, S. A. Quezada, J. P. Allison, Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy. Immunol. Rev. 224, 141-165 (2008).
-
(2008)
Immunol. Rev.
, vol.224
, pp. 141-165
-
-
Peggs, K.S.1
Quezada, S.A.2
Allison, J.P.3
-
44
-
-
38549089084
-
The reverse stop-signal model for CTLA4 function
-
C. E. Rudd, The reverse stop-signal model for CTLA4 function. Nat. Rev. Immunol. 8, 153-160 (2008).
-
(2008)
Nat. Rev. Immunol.
, vol.8
, pp. 153-160
-
-
Rudd, C.E.1
-
45
-
-
78650034777
-
Towards a knowledge-based Human Protein Atlas
-
M. Uhlen, P. Oksvold, L. Fagerberg, E. Lundberg, K. Jonasson, M. Forsberg, M. Zwahlen, C. Kampf, K. Wester, S. Hober, H. Wernerus, L. Björling, F. Ponten, Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250 (2010).
-
(2010)
Nat. Biotechnol.
, vol.28
, pp. 1248-1250
-
-
Uhlen, M.1
Oksvold, P.2
Fagerberg, L.3
Lundberg, E.4
Jonasson, K.5
Forsberg, M.6
Zwahlen, M.7
Kampf, C.8
Wester, K.9
Hober, S.10
Wernerus, H.11
Björling, L.12
Ponten, F.13
-
46
-
-
53549116447
-
HLA antigen changes in malignant cells: Epigenetic mechanisms and biologic significance
-
M. Campoli, S. Ferrone, HLA antigen changes in malignant cells: Epigenetic mechanisms and biologic significance. Oncogene 27, 5869-5885 (2008).
-
(2008)
Oncogene
, vol.27
, pp. 5869-5885
-
-
Campoli, M.1
Ferrone, S.2
-
47
-
-
52049115449
-
OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation
-
Y. Cui, Y. Ying, A. van Hasselt, K. M. Ng, J. Yu, Q. Zhang, J. Jin, D. Liu, J. S. Rhim, S. Y. Rha, M. Loyo, A. T. Chan, G. Srivastava, G. S. Tsao, G. C. Sellar, J. J. Sung, D. Sidransky, Q. Tao, OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLOS One 3, e2990 (2008).
-
(2008)
PLOS One
, vol.3
-
-
Cui, Y.1
Ying, Y.2
Van Hasselt, A.3
Ng, K.M.4
Yu, J.5
Zhang, Q.6
Jin, J.7
Liu, D.8
Rhim, J.S.9
Rha, S.Y.10
Loyo, M.11
Chan, A.T.12
Srivastava, G.13
Tsao, G.S.14
Sellar, G.C.15
Sung, J.J.16
Sidransky, D.17
Tao, Q.18
-
48
-
-
35549013060
-
p53 target gene SMAR1 is dysregulated in breast cancer: Its role in cancer cell migration and invasion
-
K. Singh, D. Mogare, R. O. Giridharagopalan, R. Gogiraju, G. Pande, S. Chattopadhyay, p53 target gene SMAR1 is dysregulated in breast cancer: Its role in cancer cell migration and invasion. PLOS One 2, e660 (2007).
-
(2007)
PLOS One
, vol.2
-
-
Singh, K.1
Mogare, D.2
Giridharagopalan, R.O.3
Gogiraju, R.4
Pande, G.5
Chattopadhyay, S.6
-
49
-
-
79952247951
-
Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells
-
L. Meimei, L. Peiling, L. Baoxin, L. Changmin, Z. Rujin, H. Chunjie, Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells. Med. Oncol. 28, 282-289 (2011).
-
(2011)
Med. Oncol.
, vol.28
, pp. 282-289
-
-
Meimei, L.1
Peiling, L.2
Baoxin, L.3
Changmin, L.4
Rujin, Z.5
Chunjie, H.6
-
50
-
-
84859427921
-
Two opposing roles of O-glycans in tumor metastasis
-
S. Tsuboi, S. Hatakeyama, C. Ohyama, M. Fukuda, Two opposing roles of O-glycans in tumor metastasis. Trends Mol. Med. 18, 224-232 (2012).
-
(2012)
Trends Mol. Med.
, vol.18
, pp. 224-232
-
-
Tsuboi, S.1
Hatakeyama, S.2
Ohyama, C.3
Fukuda, M.4
-
51
-
-
33745700090
-
Differential expression of N-cadherin and E-cadherin in normal human tissues
-
B. Tsuchiya, Y. Sato, T. Kameya, I. Okayasu, K. Mukai, Differential expression of N-cadherin and E-cadherin in normal human tissues. Arch. Histol. Cytol. 69, 135-145 (2006).
-
(2006)
Arch. Histol. Cytol.
, vol.69
, pp. 135-145
-
-
Tsuchiya, B.1
Sato, Y.2
Kameya, T.3
Okayasu, I.4
Mukai, K.5
-
52
-
-
79953147370
-
A perspective on cancer cellmetastasis
-
C. L. Chaffer, R. A. Weinberg, A perspective on cancer cellmetastasis. Science 331, 1559-1564 (2011).
-
(2011)
Science
, vol.331
, pp. 1559-1564
-
-
Chaffer, C.L.1
Weinberg, R.A.2
-
53
-
-
36849021712
-
T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection
-
M. T. Stephan, V. Ponomarev, R. J. Brentjens, A. H. Chang, K. V. Dobrenkov, G. Heller, M. Sadelain, T cell-encoded CD80 and 4-1BBL induce auto- and transcostimulation, resulting in potent tumor rejection. Nat. Med. 13, 1440-1449 (2007).
-
(2007)
Nat. Med.
, vol.13
, pp. 1440-1449
-
-
Stephan, M.T.1
Ponomarev, V.2
Brentjens, R.J.3
Chang, A.H.4
Dobrenkov, K.V.5
Heller, G.6
Sadelain, M.7
-
54
-
-
77449115224
-
Natural killer cell conjugate assay using two-color flow cytometry
-
D. N. Burshtyn, C. Davidson, Natural killer cell conjugate assay using two-color flow cytometry. Methods Mol. Biol. 612, 89-96 (2010).
-
(2010)
Methods Mol. Biol.
, vol.612
, pp. 89-96
-
-
Burshtyn, D.N.1
Davidson, C.2
-
55
-
-
84885612102
-
Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy
-
M. Themeli, C. C. Kloss, G. Ciriello, V. D. Fedorov, F. Perna, M. Gonen, M. Sadelain, Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy. Nat. Biotechnol. 31, 928-933 (2013).
-
(2013)
Nat. Biotechnol.
, vol.31
, pp. 928-933
-
-
Themeli, M.1
Kloss, C.C.2
Ciriello, G.3
Fedorov, V.D.4
Perna, F.5
Gonen, M.6
Sadelain, M.7
-
56
-
-
11844304390
-
+ cytolytic T lymphocyte responses
-
+ cytolytic T lymphocyte responses. J. Immunol. 174, 758-766 (2005).
-
(2005)
J. Immunol.
, vol.174
, pp. 758-766
-
-
Yuan, J.1
Latouche, J.B.2
Reagan, J.L.3
Heller, G.4
Riviere, I.5
Sadelain, M.6
Young, J.W.7
|